hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223

Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed, but microRNA (miR)-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-22...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology: Gastrointestinal and liver physiology Vol. 319; no. 6; pp. G703 - G717
Main Authors Zhang, Xiutian, Tan, Peng, Zhuang, Yuan, Du, Lei
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed, but microRNA (miR)-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment. Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition. NEW & NOTEWORTHY Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed but microRNA (miR)R-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment.
AbstractList Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition. Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed but microRNA (miR)R-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment.
Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition.
Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition.NEW & NOTEWORTHY Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed but microRNA (miR)R-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment.Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition.NEW & NOTEWORTHY Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed but microRNA (miR)R-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment.
Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed, but microRNA (miR)-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment. Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose certain cancers or act as targets for cancer treatment. We aimed to explore the functions of human circular RNA 001587 (hsa_circRNA_001587) on the progression of PC and the underlying mechanism. The expression pattern of hsa_circRNA_001587 and microRNA-223 (miR-223) in PC tissues and cells was determined by RT-qPCR. Dual-luciferase reporter gene assay, RNA-pulldown, Argonaute 2 (AGO2) immunoprecipitation assay, and Northern blot analysis were applied to verify the binding relationships among hsa_circRNA_001587, miR-223 and solute carrier family 4 member 4 (SLC4A4). Further analysis of their roles was performed in PC cell line PANC-1. Moreover, we either downregulated or upregulated the expression of hsa_circRNA_001587, miR-223, and SLC4A4 by transfection in vitro. A mouse xenograft model of PC cells was established to evaluate tumor growth in vivo. hsa_circRNA_001587 was poorly expressed, but miR-223 was highly expressed in PC tissues and cell lines. Upregulation of hsa_circRNA_001587 downregulated the expression of matrix metalloproteinase-2 and-9, minichromosome maintenance 2, and vascular endothelial growth factor, and decreased the proliferation, migration, invasion, angiogenic and tumorigenic abilities of PC cells. MiR-223, which can bind with hsa_circRNA_001587, reversed the effects of hsa_circRNA_001587 on PC cells. In addition, SLC4A4 was identified as a target of miR-223, and its knockdown could counteract the regulatory effects of overexpressed hsa_circRNA_001587 or inhibited miR-223 expression on PC cells. Therefore, hsa_circRNA_001587 inhibits PC cell migration, invasion, angiogenesis and tumorigenesis by impairing miR-223-mediated SLC4A4 inhibition. NEW & NOTEWORTHY Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed but microRNA (miR)R-223 is overexpressed in pancreatic cancer (PC) cells. hsa_circRNA_001587 binds to miR-223. Overexpression of hsa_circRNA_001587 inhibits PC progression. Overexpression of miR-223 downregulates the expression of SLC4A4 and promotes PC cell growth. hsa_circRNA_001587 may be a potential target for PC treatment.
Author Zhuang, Yuan
Du, Lei
Tan, Peng
Zhang, Xiutian
Author_xml – sequence: 1
  givenname: Xiutian
  surname: Zhang
  fullname: Zhang, Xiutian
  organization: Department of Gastroenterology, Linyi People's Hospital, Linyi, China
– sequence: 2
  givenname: Peng
  surname: Tan
  fullname: Tan, Peng
  organization: Internal Medicine Teaching and Research Section, Shandong Medical College, Linyi, China
– sequence: 3
  givenname: Yuan
  surname: Zhuang
  fullname: Zhuang, Yuan
  organization: Histology and Embryology Teaching and Research Section, Shandong Medical College, Linyi, China
– sequence: 4
  givenname: Lei
  surname: Du
  fullname: Du, Lei
  organization: Department of Oncology, Linyi People's Hospital, Linyi, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32878470$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtr3DAUhUVISSZp9lkFQTZd1FO9bEvLYegLhhb6WAtZlp072JIj2aH9J_251UySLgJdCF0O3706uucCnfrgHULXlKwpLdk7s596WBNCqVwzwsgJWmWZFbQU9SlaEap4QWVZn6OLlPaEkJJReobOOZO1FDVZoT93yWgL0X77stF5UClrvEzR9ctgZpfw991WbAR2v7KWEgSP54DB30EDMx6hj2bO4tssPZh0rIxv8-kh9M67BAmHDk_G2-gyarHNpYvYumFI-AEMbsC34PvD3BFsDNlIwRh_jV51Zkju6um-RD8_vP-x_VTsvn78vN3sCssVnwslHKFWdRVXZde6hnSis5Rb1jDDqJSl4TWvKuWotFxKo1TbGF51grNKlIbyS_Tmce4Uw_3i0qxHSAd3xruwJM0EV6pWSpCM3r5A92GJPrvLVKWkyO_xTN08UUszulZPEUYTf-vnnWeAPAL5sylF1_1DKNGHWPUxVn2MVR9izS3VixYL83HzczQw_L_xL7adpr4
CitedBy_id crossref_primary_10_3390_cancers13164161
crossref_primary_10_1186_s12935_021_02392_y
crossref_primary_10_1016_j_drudis_2022_05_012
crossref_primary_10_1002_cbin_12049
crossref_primary_10_1016_j_critrevonc_2024_104612
crossref_primary_10_1002_jbt_23274
crossref_primary_10_1186_s13046_023_02894_9
crossref_primary_10_3390_jpm11020127
crossref_primary_10_1002_cam4_5499
crossref_primary_10_1016_j_pharmthera_2021_107869
crossref_primary_10_18632_aging_203740
crossref_primary_10_1038_s41598_022_13212_2
crossref_primary_10_1007_s10585_022_10197_0
crossref_primary_10_3389_fcell_2022_1023332
crossref_primary_10_1038_s41598_023_28439_w
crossref_primary_10_1186_s13765_022_00716_8
crossref_primary_10_1007_s11033_022_07723_4
crossref_primary_10_1007_s12094_021_02599_5
crossref_primary_10_1007_s12094_023_03178_6
crossref_primary_10_1080_08820139_2021_2001496
crossref_primary_10_3390_cancers14246187
crossref_primary_10_1016_j_semcancer_2020_12_026
crossref_primary_10_1007_s12672_024_01488_x
crossref_primary_10_1038_s43018_022_00470_2
crossref_primary_10_1007_s00424_024_02937_w
crossref_primary_10_1016_j_ncrna_2023_12_002
crossref_primary_10_2147_CMAR_S308809
crossref_primary_10_1097_JP9_0000000000000087
crossref_primary_10_1186_s13578_022_00833_3
crossref_primary_10_3390_cancers12113250
crossref_primary_10_1002_ctm2_356
crossref_primary_10_1080_08916934_2021_1963958
crossref_primary_10_3390_ijms25158191
crossref_primary_10_1038_s41598_022_23764_y
crossref_primary_10_1016_j_omton_2024_200919
crossref_primary_10_3390_biom14010060
crossref_primary_10_1007_s12033_023_00874_0
crossref_primary_10_1002_jcla_24247
crossref_primary_10_1016_j_prp_2022_153833
crossref_primary_10_1016_j_canlet_2024_217070
crossref_primary_10_3390_ijms242015166
crossref_primary_10_3389_fmolb_2022_893846
Cites_doi 10.1371/journal.pone.0164150
10.1016/j.bbrc.2018.06.089
10.1136/bmj.e2476
10.1038/s41571-018-0112-1
10.1053/j.gastro.2016.09.060
10.1038/cddis.2017.556
10.1016/j.ymthe.2019.05.011
10.1007/s10456-017-9556-7
10.26355/eurrev_201909_19000
10.1159/000375164
10.3892/mmr.2018.8827
10.3390/ijms20020296
10.2217/fon-2016-0010
10.3748/wjg.v22.i44.9694
10.1038/s41576-019-0158-7
10.7754/Clin.Lab.2017.170731
10.1002/iub.1315
10.3748/wjg.v23.i47.8345
10.7717/peerj.7968
10.1080/15384047.2019.1617563
10.1186/s13046-019-1041-2
10.1016/S0140-6736(16)00141-0
10.1016/j.molcel.2016.09.027
10.3727/096504016X14685034103437
10.1016/j.canlet.2015.06.003
10.15252/embj.2018100836
10.1038/bjc.2016.451
10.3233/CBM-181877
10.1186/s12943-015-0327-z
10.1016/j.biopha.2018.10.177
10.1136/jmedgenet-2016-103758
10.2147/OTT.S150678
10.1016/j.canlet.2019.02.051
10.1042/CS20190286
10.1016/j.bbrc.2018.09.073
10.1001/jama.2013.284664
10.18632/aging.101763
10.1155/2020/1204605
10.1155/2019/7630894
10.1097/CM9.0000000000000465
ContentType Journal Article
Copyright Copyright American Physiological Society Dec 2020
Copyright_xml – notice: Copyright American Physiological Society Dec 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1152/ajpgi.00118.2020
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1522-1547
EndPage G717
ExternalDocumentID 32878470
10_1152_ajpgi_00118_2020
Genre Journal Article
GroupedDBID ---
23M
2WC
39C
4.4
5GY
5VS
6J9
AAFWJ
AAYXX
ABJNI
ACPRK
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKKCC
BKOMP
CITATION
E3Z
EBS
EMOBN
F5P
GX1
H13
ITBOX
KQ8
OK1
P2P
PQQKQ
RAP
RHI
RPL
RPRKH
TR2
W8F
WOQ
XSW
YSK
CGR
CUY
CVF
DIK
ECM
EIF
NPM
RHF
K9.
7X8
ID FETCH-LOGICAL-c393t-94e01c9f6395fdeb0f4fc13c2b2a21885a373669e18c388a99dba36f432645a13
ISSN 0193-1857
1522-1547
IngestDate Fri Jul 11 03:21:49 EDT 2025
Mon Jun 30 07:52:23 EDT 2025
Thu Jan 02 22:57:39 EST 2025
Tue Jul 01 03:43:04 EDT 2025
Thu Apr 24 23:02:34 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords microRNA-223
pancreatic cancer
invasion
angiogenesis
migration
solute carrier family 4 member 4
hsa_circular RNA 001587
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c393t-94e01c9f6395fdeb0f4fc13c2b2a21885a373669e18c388a99dba36f432645a13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 32878470
PQID 2469841883
PQPubID 48585
ParticipantIDs proquest_miscellaneous_2439979940
proquest_journals_2469841883
pubmed_primary_32878470
crossref_primary_10_1152_ajpgi_00118_2020
crossref_citationtrail_10_1152_ajpgi_00118_2020
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-12-01
20201201
PublicationDateYYYYMMDD 2020-12-01
PublicationDate_xml – month: 12
  year: 2020
  text: 2020-12-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda
PublicationTitle American journal of physiology: Gastrointestinal and liver physiology
PublicationTitleAlternate Am J Physiol Gastrointest Liver Physiol
PublicationYear 2020
Publisher American Physiological Society
Publisher_xml – name: American Physiological Society
References B20
B42
B21
B22
B23
Chien YC (B9) 2018; 8
B24
Pishvaian MJ (B30) 2017; 31
B25
B26
B27
B28
B29
B31
B10
B32
B11
B33
B12
B34
B13
B35
B14
B36
B15
B37
B16
B38
B17
B39
B18
B19
B1
B2
B3
B4
B5
B6
B7
B8
B40
B41
References_xml – ident: B29
  doi: 10.1371/journal.pone.0164150
– ident: B41
  doi: 10.1016/j.bbrc.2018.06.089
– ident: B6
  doi: 10.1136/bmj.e2476
– ident: B35
  doi: 10.1038/s41571-018-0112-1
– ident: B16
  doi: 10.1053/j.gastro.2016.09.060
– ident: B34
  doi: 10.1038/cddis.2017.556
– ident: B32
  doi: 10.1016/j.ymthe.2019.05.011
– ident: B1
  doi: 10.1007/s10456-017-9556-7
– ident: B15
  doi: 10.26355/eurrev_201909_19000
– ident: B13
  doi: 10.1159/000375164
– volume: 8
  start-page: 422
  year: 2018
  ident: B9
  publication-title: Am J Cancer Res
– ident: B12
  doi: 10.3892/mmr.2018.8827
– ident: B27
  doi: 10.3390/ijms20020296
– ident: B3
  doi: 10.2217/fon-2016-0010
– ident: B17
  doi: 10.3748/wjg.v22.i44.9694
– ident: B21
  doi: 10.1038/s41576-019-0158-7
– volume: 31
  start-page: 159
  year: 2017
  ident: B30
  publication-title: Oncology (Williston Park)
– ident: B25
  doi: 10.7754/Clin.Lab.2017.170731
– ident: B2
  doi: 10.1002/iub.1315
– ident: B39
  doi: 10.3748/wjg.v23.i47.8345
– ident: B26
  doi: 10.7717/peerj.7968
– ident: B36
  doi: 10.1080/15384047.2019.1617563
– ident: B38
  doi: 10.1186/s13046-019-1041-2
– ident: B20
  doi: 10.1016/S0140-6736(16)00141-0
– ident: B10
  doi: 10.1016/j.molcel.2016.09.027
– ident: B14
  doi: 10.3727/096504016X14685034103437
– ident: B31
  doi: 10.1016/j.canlet.2015.06.003
– ident: B28
  doi: 10.15252/embj.2018100836
– ident: B23
  doi: 10.1038/bjc.2016.451
– ident: B19
  doi: 10.3233/CBM-181877
– ident: B24
  doi: 10.1186/s12943-015-0327-z
– ident: B4
  doi: 10.1016/j.biopha.2018.10.177
– ident: B8
  doi: 10.1136/jmedgenet-2016-103758
– ident: B7
  doi: 10.2147/OTT.S150678
– ident: B18
  doi: 10.1016/j.canlet.2019.02.051
– ident: B11
  doi: 10.1042/CS20190286
– ident: B5
  doi: 10.1016/j.bbrc.2018.09.073
– ident: B33
  doi: 10.1001/jama.2013.284664
– ident: B37
  doi: 10.18632/aging.101763
– ident: B42
  doi: 10.1155/2020/1204605
– ident: B40
  doi: 10.1155/2019/7630894
– ident: B22
  doi: 10.1097/CM9.0000000000000465
SSID ssj0005211
Score 2.5589895
Snippet Human circular (hsa_circ)RNA_001587 and solute carrier family 4 member 4 (SLC4A4) are poorly expressed, but microRNA (miR)-223 is overexpressed in pancreatic...
Pancreatic cancer (PC) is a malignant tumor that is difficult to diagnose and treat. Circular RNAs (circRNAs) are biomarkers that may be used to diagnose...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage G703
SubjectTerms Adult
Aged
Angiogenesis
Animals
Argonaute 2 protein
Cell adhesion & migration
Cell Line, Tumor
Cell migration
Cell Movement - genetics
Cell proliferation
Circular RNA
Female
Humans
Immunoprecipitation
Male
Matrix metalloproteinase
Matrix Metalloproteinase 2 - metabolism
Matrix Metalloproteinase 9 - metabolism
Metalloproteinase
Mice
Mice, Inbred BALB C
Mice, Nude
MicroRNAs
MicroRNAs - genetics
MicroRNAs - metabolism
Middle Aged
miRNA
Neoplasm Invasiveness - genetics
Neovascularization, Pathologic - genetics
Pancreatic cancer
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - pathology
Pheochromocytoma cells
Reporter gene
RNA, Circular - genetics
Sodium-Bicarbonate Symporters - biosynthesis
Sodium-Bicarbonate Symporters - genetics
Transfection
Tumorigenesis
Up-Regulation - genetics
Vascular endothelial growth factor
Xenograft Model Antitumor Assays
Xenografts
Title hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223
URI https://www.ncbi.nlm.nih.gov/pubmed/32878470
https://www.proquest.com/docview/2469841883
https://www.proquest.com/docview/2439979940
Volume 319
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKkKa9INiAFQYyEkJCWVhqO038WA3YxJ9pQCeVp8pxnc5oTao2mQSfhE_E5-JsJ2mgGwJeoii-Omnul_Pd-eczQk9TEdJA8tCnQcp9JiPlJ3EkAcuExGoyMdUBDNvipH98xt6MwlGn86PFWiqL5IX8duW6kv_RKlwDvZpVsv-g2aZTuADnoF84gobh-Fc6Pl-KsdQL-fFkYFhjYRx55XzhdpdXS-_Tu0M2YKaIvyO7ZsbR1Nm5TnThzfTUKd-8ZJ1dimV17qq3TnU-NWbQlSsBk-G8S2lYYlItPJPwX3qXWniJdgtjoO-ZYffBw_jEre5tytvW00KtOhU2peKWytCBdySWxSI3tSvA5GRV_YILwxlpCa4luUe6LFrwHrpk7qmqRmMrWlayn8uV4MvSpiOUbuc8SJs_oio7DTE0eH9R25DTyvjqNbN8FNlCCleMF6GpPyu-zKfazkkZsp9dnFe04DOfWfxQCC5hLA9WI2fDZ6ybbqCbBMIVs5PG2w9xi2rU69VT5CE5-P12W2iz7uBX7-iakMe6PsPb6FYVs-CBA-Ad1FHZNtoZZKLIZ1_xM3zaaGgbbb6vyBo76Ps6PHELntjBE6_giYscV_DEDTz3cQ3OfQygwG1o4jzFK2hiB01soYkBmriCpum3Dc276Oz1q-HhsV9tBOJLymnhc6aCnuQpeNNhOlFJkLJU9qgkCRHgosahoBHt97nqxZLGseB8kgjaTxnEJiwUPXoPbWR5pnYRZlzFIQkmEDdwFrNA9NMEQog-AbeX8CToooNaAfCGHBvGbNZyMbbRckjGVnuWChqPjfa66Hnzi7mrEPMH2b1ap-Pqi1uOidnElcHfoF30pGkGK29el8hUXhoZCCQizhl0cd9hoblZjZ0H17Y8RFurr2gPbRSLUj0CX7pIHlug_gQ7zcno
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=hsa_circRNA_001587+upregulates+SLC4A4+expression+to+inhibit+migration%2C+invasion%2C+and+angiogenesis+of+pancreatic+cancer+cells+via+binding+to+microRNA-223&rft.jtitle=American+journal+of+physiology%3A+Gastrointestinal+and+liver+physiology&rft.au=Zhang%2C+Xiutian&rft.au=Tan%2C+Peng&rft.au=Zhuang%2C+Yuan&rft.au=Du%2C+Lei&rft.date=2020-12-01&rft.eissn=1522-1547&rft.volume=319&rft.issue=6&rft.spage=G703&rft_id=info:doi/10.1152%2Fajpgi.00118.2020&rft_id=info%3Apmid%2F32878470&rft.externalDocID=32878470
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0193-1857&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0193-1857&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0193-1857&client=summon